Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (93 ops.)
Latest filing published 23 Jul 2026 for VERTEX PHARMACEUTICALS INC / MA.
Filing timeline
BuySaleOurania Tatsis
Insider track record
Disclosed buys
0
Disclosed sells
93
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Ourania Tatsis: trading record in brief
Ourania Tatsis, listed as senior executive, appears in our data through filings on Vertex Pharmaceuticals INC / MA shares, published by SEC (Form 4). The record holds 144 filings, for trades running from 1 October 2019 to 21 July 2026.
Every open-market trade on record is a sale: 93 sales worth €19.3M. Other entries cover 45 share grants and 6 option exercises. In 2026 alone, the filings show no purchases and 7 sales.
The latest filing, published on 23 July 2026, reports a share grant in Vertex Pharmaceuticals INC / MA. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ourania Tatsis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations37 total
8,251 shares0Common StockSEC:0000875320-26-000253:0
1,500 shares@ US$524.990.0006% mcap3.0% of flowCommon StockSEC:0000875320-26-000245:0
1,627 shares@ US$485.119.1% of flowCommon StockSEC:0000875320-26-000120:0
5,789 shares0Common StockSEC:0000875320-26-000098:0
3,804 shares@ US$487.7621.3% of flowCommon StockSEC:0000875320-26-000076:0
2,140 shares@ US$468.4111.5% of flowCommon StockSEC:0000875320-26-000052:0
7,866 shares0Common StockSEC:0000875320-26-000026:0
4,500 shares@ US$474.9924.9% of flowCommon StockSEC:0000875320-26-000004:0
4,500 shares@ US$449.9971.6% of flowCommon StockSEC:0000875320-25-000244:0
3,242 shares@ US$499.996.6% of flowCommon StockSEC:0000875320-25-000146:0
4,058 shares@ US$485.498.3% of flowCommon StockSEC:0000875320-25-000141:0
4,962 shares@ US$479.6110.0% of flowCommon StockSEC:0000875320-25-000135:0
3,310 shares@ US$483.286.8% of flowCommon StockSEC:0000875320-25-000115:0
2,293 shares@ US$463.464.5% of flowCommon StockSEC:0000875320-25-000095:0
6,211 shares0Common StockSEC:0000875320-25-000073:0
2,143 shares@ US$467.984.3% of flowCommon StockSEC:0000875320-25-000048:0
10,262 shares0Common StockSEC:0000875320-25-000024:0
2,175 shares@ US$460.004.1% of flowCommon StockSEC:0000875320-24-000168:0
2,350 shares@ US$439.114.2% of flowCommon StockSEC:0000875320-24-000166:0
3,309 shares@ US$431.795.8% of flowCommon StockSEC:0000875320-24-000109:0
360 shares@ US$421.770.6% of flowCommon StockSEC:0000875320-24-000093:0
4,499 shares@ US$424.017.8% of flowCommon StockSEC:0000875320-24-000080:0
2,100 shares@ US$422.743.6% of flowCommon StockSEC:0000875320-24-000055:0
6,976 shares0Common StockSEC:0000875320-24-000032:0
2,500 shares@ US$355.003.6% of flowCommon StockSEC:0001209191-23-047309:0
25 of 37 declarations
